Diabetes:

Indications for ZEGALOGUE:

Severe hypoglycemia.

Adults and Children:

<6yrs: not established. Give by SC inj into lower abdomen, buttocks, thighs, or outer upper arm. ≥6yrs: 0.6mg. May repeat if no response after 15mins. After responding, give oral carbohydrates.

ZEGALOGUE Contraindications:

Pheochromocytoma. Insulinoma.

ZEGALOGUE Warnings/Precautions:

Instruct caregivers in proper use. Previously undiagnosed pheochromocytoma. Lack of efficacy in insulinoma; may cause hypoglycemia. If hypoglycemia develops after treatment, give oral or IV glucose. Insufficient hepatic glycogen reserves (eg, starvation, adrenal insufficiency, chronic hypoglycemia); treat with glucose. Pregnancy. Nursing mothers.

ZEGALOGUE Classification:

Antihypoglycemic.

ZEGALOGUE Interactions:

Transient increase in pulse and blood pressure may occur with beta-blockers. Loss of efficacy or may produce hypoglycemia with indomethacin. May potentiate the anticoagulant effect of warfarin.

Adverse Reactions:

Nausea, vomiting, headache, inj site pain; adults also: diarrhea; hypersensitivity reactions.

Generic Drug Availability:

NO

How Supplied:

Single-dose prefilled syringe, single-dose autoinjector—1, 2

Pricing for ZEGALOGUE

two autoinjectors of 0.6mg/0.6ml carton (Qty: 1)
Appx. price $640
GoodRx